Press release
U.S. Benign Prostatic Hyperplasia Surgical Treatment Market Projected to Reach USD 1,232.65 Million by 2034, Expanding at a CAGR of 5.6%
Polaris Market Research announces the release of its latest study on the U.S. Benign Prostatic Hyperplasia Surgical Treatment market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings,The U.S. benign prostatic hyperplasia (BPH) surgical treatment market is projected to reach USD 1,232.65 million by 2034, expanding at a CAGR of 5.6% from 2025. The market was valued at USD 714.48 million in 2024.
What is U.S. Benign Prostatic Hyperplasia Surgical Treatment?
U.S. Benign Prostatic Hyperplasia (BPH) surgical treatment involves procedures aimed at relieving urinary symptoms caused by an enlarged prostate gland. Common techniques include transurethral resection of the prostate (TURP), laser therapy, and other minimally invasive options. These surgeries are typically recommended when medications are ineffective. The goal is to improve urinary flow, reduce bladder pressure, and enhance overall quality of life for men experiencing moderate to severe BPH symptoms.
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/us-benign-prostatic-hyperplasia-surgical-treatment-market/request-for-sample
What Is the Report Scope?
Provides a comprehensive analysis of the market, including historical data, current trends, and future projections.
Covers both qualitative and quantitative insights to support strategic decision-making.
Examines key market segments and sub-segments to offer an in-depth market assessment.
Includes detailed regional analysis covering major geographic markets.
Assesses the competitive landscape with profiles of leading players, recent developments, and strategic initiatives.
U.S. Benign Prostatic Hyperplasia Surgical Treatment Market Report Highlights:
Growing Aging Population: The rising number of elderly men in the U.S. is leading to a higher prevalence of BPH, increasing the demand for surgical treatments.
Shift to Minimally Invasive Procedures: Patients and providers are preferring laser and minimally invasive surgeries due to quicker recovery and fewer complications.
Technological Advancements: Innovation in surgical tools and techniques is improving treatment accuracy and patient outcomes.
Strong Healthcare Support: Favorable reimbursement policies and advanced medical infrastructure are boosting access to BPH surgical procedures.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/us-benign-prostatic-hyperplasia-surgical-treatment-market/request-for-discount-pricing
Who Are Market Key Players?
This market features dynamic competition where prominent organizations continuously innovate and pursue strategic alliances to expand their market share and influence. Key U.S. Benign Prostatic Hyperplasia Surgical Treatment market participants include:
Boston Scientific Corporation
Cleveland Clinic
Cook Medical
Eli Lilly and Company
Medifocus, Inc.
Medtronic
PROCEPT BioRobotics Corporation
Teleflex Incorporated
The Johns Hopkins Hospital
Viatris Inc.
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/us-benign-prostatic-hyperplasia-surgical-treatment-market
Which Region Leads Market Demand?
The global market exhibits varied growth patterns across regions, with certain areas leading due to strong industrial presence, higher investment levels, and favorable economic conditions.
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
•Latin America(Mexico,Brazil,Argentina,Rest of Latin America)
How Is Market Segmentation Done?
The market segmentation section provides a clearer understanding of demand patterns and growth opportunities across different segments. The market is segmented based on the following key parameters:
By Type Outlook (Revenue, USD Million, 2020-2034)
Transurethral Resection of the Prostate (TURP)
Prostatic Urethral Lift
Water Vapor Therapy
Laser Therapy
Aquablation Therapy
Transurethral Microwave Thermotherapy (TUMT)
Others
By End User Outlook (Revenue, USD Million, 2020-2034)
Hospitals
Ambulatory Surgery Centers and Clinics
Homecare Settings
More Trending Latest Reports by Polaris Market Research:
Aesthetic Medicine Market
https://www.polarismarketresearch.com/industry-analysis/aesthetic-medicine-market
Airway Management Devices Market
https://www.polarismarketresearch.com/industry-analysis/airway-management-devices-market
Alopecia Market
https://www.polarismarketresearch.com/industry-analysis/alopecia-market
Alzheimer's Therapeutics Market
https://www.polarismarketresearch.com/industry-analysis/alzheimers-therapeutics-market
Ambulatory Care Services Market
https://www.polarismarketresearch.com/industry-analysis/ambulatory-care-services-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Benign Prostatic Hyperplasia Surgical Treatment Market Projected to Reach USD 1,232.65 Million by 2034, Expanding at a CAGR of 5.6% here
News-ID: 4100523 • Views: …
More Releases from Polaris Market Research & Consulting
U.S. Riflescopes & Red Dot Sight Market Outlook to 2034: Key Trends, Investment …
Polaris Market Research recently introduced the latest update on U.S. Riflescopes & Red Dot Sight Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the U.S. Riflescopes & Red Dot Sight market size, share, demand, key growth factors, segmentation, country-level overview, and forecast.
The report helps businesses get…
U.S. Blank Apparel Market on Track for USD 5.92 Billion By 2034, Growing at a 5. …
Polaris Market Research recently introduced the latest update on U.S. Blank Apparel Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the U.S. Blank Apparel market size, share, demand, key growth factors, segmentation, country-level overview, and forecast.
The report helps businesses get a thorough understanding of the industry…
U.S. Small Molecule CDMO Market Forecast 2025-2034: Key Trends, Growth Opportuni …
Polaris Market Research recently introduced the latest update on U.S. Small Molecule CDMO Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the U.S. Small Molecule CDMO market size, share, demand, key growth factors, segmentation, country-level overview, and forecast.
The report helps businesses get a thorough understanding of…
U.S. Liquid Embolic Agent Market Forecast to Hit USD 156.91 Million by 2034 with …
Polaris Market Research recently introduced the latest update on U.S. Liquid Embolic Agent Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the U.S. Liquid Embolic Agent market size, share, demand, key growth factors, segmentation, country-level overview, and forecast.
The report helps businesses get a thorough understanding of…
More Releases for Prostatic
Rising Geriatric Population Drives Growth Of Benign Prostatic Hypertrophy Drugs …
The Drugs For Benign Prostatic hypertrophy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Drugs For Benign Prostatic hypertrophy Market?
The drugs for benign prostatic hypertrophy market has shown strong growth, expanding from $4.28 billion in 2024 to $4.58…
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market?
The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened…
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.…
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market?
The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened…
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market?
The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened…
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.…
